Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group

被引:112
作者
Gwadry-Sridhar, Femida H. [1 ,2 ]
Manias, Elizabeth [3 ]
Lal, Lincy [4 ]
Salas, Maribel [5 ,6 ]
Hughes, Dyfrig A. [7 ]
Ratzki-Leewing, Alexandria [2 ]
Grubisic, Maja [6 ,8 ]
机构
[1] Univ Western Ontario, Dept Comp Sci, Fac Sci, London, ON, Canada
[2] Lawson Hlth Res Inst, I THINK Res, London, ON, Canada
[3] Univ Melbourne, Melbourne Sch Hlth Sci, Melbourne, Vic, Australia
[4] Ingenix, Ingenix Consulting, Houston, TX USA
[5] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[6] AstraZeneca, Wilmington, DE USA
[7] Bangor Univ, Ctr Econ & Policy Hlth, Bangor, Gwynedd, Wales
[8] Prov Hlth Care, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
关键词
hypertension; intervention; medication adherence; uncontrolled blood pressure; RANDOMIZED CONTROLLED-TRIAL; PRESCRIPTION REFILL COMPLIANCE; COMPLIANCE-IMPROVING STRATEGIES; CORONARY-HEART-DISEASE; VALUE-ADDED UTILITIES; HEALTH-EDUCATION; STRUCTURED TREATMENT; PRIMARY-CARE; PHARMACIST COLLABORATION; ANTIHYPERTENSIVE DRUGS;
D O I
10.1016/j.jval.2013.03.1631
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: To systematically review the evidence on the impact of interventions to improve medication adherence in adults prescribed antihypertensive medications. Methods: An electronic search was undertaken of articles published between 1979 and 2009, without language restriction, that focused on interventions to improve antihypertensive medication adherence among patients (>= 18 years) with essential hypertension. Studies must have measured adherence as an outcome of the intervention. We followed standard guidelines for the conduct and reporting of the review and conducted a narrative synthesis of reported data. Results: Ninety-seven articles were identified for inclusion; 35 (35 of 97, 36.1%) examined interventions to directly improve medication adherence, and the majority (58 of 97, 59.8%) were randomized controlled trials. Thirty-four (34 of 97, 35.1%) studies reported a statistically significant improvement in medication adherence. Discussion/Conclusions: Interventions aimed at improving patients' knowledge of medications possess the greatest potential clinical value in improving adherence with antihypertensive therapy. However, we identified several limitations of these studies, and advise future researchers to focus on using validated adherence measures, well-designed randomized controlled trials with relevant adherence and clinical outcomes, and guidelines on the appropriate design and analysis of adherence research.
引用
收藏
页码:863 / 871
页数:9
相关论文
共 144 条
  • [1] [Anonymous], AM J HYPERTENS 3 S
  • [2] [Anonymous], MERCK FROSST PHARM R
  • [3] [Anonymous], 1995, PREDICTING HLTH BEHA
  • [4] [Anonymous], J FAM PRACT
  • [5] [Anonymous], ATEN PRIMARIA
  • [6] [Anonymous], 2013, Adherence to Long-Term Therapies: Evidence for Action, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.321-324.1779
  • [7] [Anonymous], 2003, S A J PHYSIOTHER
  • [8] [Anonymous], J HYPERTENS
  • [9] [Anonymous], 2005, THEORY GLANCE GUIDE
  • [10] [Anonymous], J COMPLIANCE HLTH CA